公开(公告)号：US20240358919A1

公开(公告)日：2024-10-31

申请号：US18764688

申请日：2024-07-05

申请人： Abbott Diabetes Care Inc.

发明人： Erwin S. BUDIMAN ,  Gary A. HAYTER ,  Nathan C. CROUTHER ,  Marc B. TAUB ,  Wesley Scott HARPER ,  Charles WEI

IPC分类号： A61M5/172 ,  A61B5/00 ,  A61B5/145 ,  A61B5/1495 ,  A61M5/142 ,  G16H20/17

CPC分类号： A61M5/1723 ,  A61B5/14532 ,  A61B5/1495 ,  A61B5/4839 ,  G16H20/17 ,  A61B2562/0295 ,  A61M2005/14208 ,  A61M2005/14296 ,  A61M2205/3569 ,  A61M2205/52 ,  A61M2230/201

摘要： Systems comprising: an analyte sensor for providing an analyte signal representative of an analyte level; a controller in data communication with the analyte sensor and programmed to provide a recommended medication dose based on the analyte level and a medication type, the controller comprising a user interface for inputting the medication type; and a model-based safety mechanism integrated with the controller for evaluating the recommended medication dose. Wherein the model-based safety mechanism overrides the recommended medication dose and provides a safety medication dose when the model-based safety mechanism detects a risk of insulin deprivation.